|
Viral Oncology Training Grant
|
3T32CA009111-38S1
|
$13,628
|
$1,363
|
CULLEN, BRYAN
|
DUKE UNIVERSITY
|
|
Viral Oncology Training Grant
|
5T32CA009111-39
|
$387,094
|
$38,709
|
CULLEN, BRYAN
|
DUKE UNIVERSITY
|
|
USC Norris Comprehensive Cancer Center (Core) Grant
|
3P30CA014089-42S1
|
$59,999
|
$9,000
|
Wayne, Alan
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
USC Norris Comprehensive Cancer Center (Core) Grant
|
5P30CA014089-42
|
$6,263,488
|
$939,523
|
Wayne, Alan
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
Unmasking the roles of KSHV glycoproteins in virus entry and vaccine development
|
5K01CA184388-04
|
$108,798
|
$108,798
|
OGEMBO, JAVIER
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
UM CFAR SCCC Argentina Consortium for research and training in Virally Induced AIDS Malignancies
|
1U54CA221208-01
|
$731,876
|
$263,475
|
MESRI, ENRIQUE
|
UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
|
|
Uganda-UCSF Consortium on Prevention and Early Detection of HIV-Associated Cancer
|
5U54CA190153-04
|
$1
|
$1
|
MARTIN, JEFFREY
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Training in Tumor Virology
|
2T32CA115299-11
|
$369,654
|
$73,931
|
ROBERTSON, ERLE
|
UNIVERSITY OF PENNSYLVANIA
|
|
Training In Tumor Virology
|
3T32CA115299-10S1
|
$3,684
|
$737
|
ROBERTSON, ERLE
|
UNIVERSITY OF PENNSYLVANIA
|
|
The Zambia AIDS Malignancies Diagnosis and Pathogenesis Program (ZAMDAPP)
|
1U54CA221204-01
|
$670,280
|
$341,843
|
WOOD, CHARLES
|
UNIVERSITY OF NEBRASKA LINCOLN
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
3P30CA060553-23S1
|
$204,369
|
$2,044
|
PLATANIAS, LEONIDAS
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
3P30CA060553-23S2
|
$57,797
|
$578
|
PLATANIAS, LEONIDAS
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
3P30CA060553-23S3
|
$79,482
|
$795
|
PLATANIAS, LEONIDAS
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
5P30CA060553-23
|
$4,865,652
|
$48,657
|
PLATANIAS, LEONIDAS
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
Targeting KSHV malignancies and persistent infection
|
5R01CA197153-03
|
$377,438
|
$377,438
|
GAO, SHOU-JIANG
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
Targeted Therapies for HIV-Associated Kaposi Sarcoma and Lymphoma
|
5R01CA163217-07
|
$342,759
|
$171,380
|
DITTMER, DIRK
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
Studying the role of KSHV-encoded miRNAs
|
5R01CA119917-10
|
$301,913
|
$301,913
|
RENNE, ROLF
|
UNIVERSITY OF FLORIDA
|
|
Study of Tumor Pathogenesis and Development of Therapies for AIDS Malignancies
|
ZIA BC 010885
|
$924,476
|
$277,343
|
Yarchoan, Robert
|
CCR (NCI)
|
|
Study of Structures of CCR5 and Its Interactions with CCR5 Inhibitors
|
ZIA BC 011109
|
$42,641
|
$2,132
|
Mitsuya, Hiroaki
|
CCR (NCI)
|
|
Studies on drug resistance in HIV-related Kaposi's sarcoma
|
ZIA BC 011730
|
$83,962
|
$41,981
|
Gottesman, Michael
|
CCR (NCI)
|
|
Studies of HHV-8 vIL-6 Function
|
5R01CA076445-16
|
$384,750
|
$192,375
|
NICHOLAS, JOHN
|
JOHNS HOPKINS UNIVERSITY
|
|
Role of KSHV viral proteins in signaling and pathogenesis
|
5R01CA096500-15
|
$281,108
|
$281,108
|
DAMANIA, BLOSSOM
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
Rhesus HHV-8 homologue in AIDS-related malignancies
|
5R01CA075922-21
|
$794,238
|
$794,238
|
WONG, SCOTT
|
OREGON HEALTH & SCIENCE UNIVERSITY
|
|
Research Management and Support
|
RMS ES 2017
|
$326,124,631
|
$21,000
|
N/A
|
National Institutes of Health
|
|
Regulation of KSHV infection and replication by MAPK pathways
|
5R01CA124332-11
|
$304,095
|
$304,095
|
GAO, SHOU-JIANG
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
Regional Oncology Research Center
|
2P30CA006973-54
|
$7,060,038
|
$70,600
|
NELSON, WILLIAM
|
JOHNS HOPKINS UNIVERSITY
|
|
Regional Oncology Research Center
|
3P30CA006973-54S1
|
$125,000
|
$1,250
|
NELSON, WILLIAM
|
JOHNS HOPKINS UNIVERSITY
|
|
Regional Oncology Research Center
|
3P30CA006973-54S2
|
$60,000
|
$600
|
NELSON, WILLIAM
|
JOHNS HOPKINS UNIVERSITY
|
|
Regional Oncology Research Center
|
3P30CA006973-54S3
|
$25,000
|
$250
|
NELSON, WILLIAM
|
JOHNS HOPKINS UNIVERSITY
|
|
Receptor Mediated SPECT Imaging Of Kaposi Sarcoma With 99mTc-Tilmanocept
|
5R44CA192859-03
|
$866,508
|
$866,508
|
COPE, FREDERICK
|
NAVIDEA BIOPHARMACEUTICALS, INC.
|
|
Reactivation of Kaposi's Sarcoma-Associated Herpesvirus
|
5R01CA091791-15
|
$284,547
|
$284,547
|
SUN, REN
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
Patient Oriented Research in Viral Malignancies and HIV-associated Cancers
|
ZIA BC 011700
|
$55,714
|
$22,286
|
Uldrick, Thomas
|
CCR (NCI)
|
|
OHSU Knight Cancer Institute
|
2P30CA069533-19
|
$2,310,000
|
$161,700
|
DRUKER, BRIAN
|
OREGON HEALTH & SCIENCE UNIVERSITY
|
|
OHSU Knight Cancer Institute
|
3P30CA069533-19S1
|
$124,990
|
$8,749
|
DRUKER, BRIAN
|
OREGON HEALTH & SCIENCE UNIVERSITY
|
|
OHSU Knight Cancer Institute
|
3P30CA069533-19S2
|
$174,792
|
$12,235
|
DRUKER, BRIAN
|
OREGON HEALTH & SCIENCE UNIVERSITY
|
|
Noncoding RNAs in gamma-Herpesvirus Biology and AIDS Malignancies
|
1P01CA214091-01
|
$1,356,357
|
$244,144
|
RENNE, ROLF
|
UNIVERSITY OF FLORIDA
|
|
NFAT activation in kGPCR tumorigenesis
|
1R01CA221521-01
|
$377,438
|
$377,438
|
FENG, PINGHUI
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
Molecular mechanisms of transcriptional regulation in the Notch pathway
|
5R01CA178974-05
|
$321,023
|
$105,938
|
KOVALL, RHETT
|
UNIVERSITY OF CINCINNATI
|
|
Molecular Diagnostics Core Laboratory
|
ZIC BC 011079
|
$1,554,465
|
$77,723
|
Raffeld, Mark
|
CCR (NCI)
|
|
Molecular Basis of KSHV oncogenesis
|
5R35CA200422-02
|
$958,770
|
$958,770
|
JUNG, JAE
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
Medical Oncology HIV-AIDS Clinical Research
|
ZID BC 011683
|
$200,544
|
$60,163
|
Gulley, James
|
CCR (NCI)
|
|
Medical Oncology Fellowship Program
|
ZIE BC 010843
|
$4,201,344
|
$210,067
|
Bilusic, Marijo
|
CCR (NCI)
|
|
Mechanism of KSHV-induced angiogenesis
|
5R01CA132637-09
|
$391,875
|
$391,875
|
GAO, SHOU-JIANG
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
Mechanism and Function of Mitophagy Regulation by HHV-8 Viral Interferon Regulatory Factor-1
|
1R01CA214131-01A1
|
$351,741
|
$351,741
|
CHOI, YOUNG BONG
|
JOHNS HOPKINS UNIVERSITY
|
|
Lipoxins and aspirin triggered lipoxins in KSHV latency and pathogenesis
|
5R01CA192970-02
|
$356,850
|
$356,850
|
SHARMA-WALIA, NEELAM
|
ROSALIND FRANKLIN UNIV OF MEDICINE & SCI
|
|
KSHV/HHV8 in sickle cell and other Ugandan populations
|
ZIA CP010176-10076
|
$4,601
|
$3,681
|
Mbulaiteye, Sam
|
DCEG (NCI)
|
|
KSHV Persistence and Pathogenesis
|
5P01CA180779-05
|
$1,472,214
|
$736,107
|
JUNG, JAE
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
KSHV interactions with host inflammasome components
|
5R01CA180758-04
|
$63,355
|
$63,355
|
CHANDRAN, BALA
|
ROSALIND FRANKLIN UNIV OF MEDICINE & SCI
|
|
KSHV interactions with host inflammasome components
|
7R01CA180758-05
|
$257,233
|
$257,233
|
CHANDRAN, BALA
|
UNIVERSITY OF SOUTH FLORIDA
|
|
KSHV Genome Replication during Primary Infection
|
5R01CA174459-05
|
$295,957
|
$198,291
|
VERMA, SUBHASH
|
UNIVERSITY OF NEVADA RENO
|
Total relevant funding to Kaposi Sarcoma for this search: $31,195,995
|